The Future of Patient-Centered Cancer Care
In today's healthcare landscape, the need for patient-centered approaches is more pressing than ever. With cancer diagnoses and mortality rates alarmingly high in certain states, innovative collaborations are being formed to enhance screening processes and improve health outcomes for patients. A new partnership between the Patient Advocate Foundation's Patient Insight Institute, Michigan Oncology Quality Consortium (MOQC), and Gilead Sciences, Inc. aims to prioritize the patient experience and subsequently improve cancer care.
Collaboration Focus
The primary objective of this partnership is to gain insights on how best to screen patients for various environmental factors that can impact health outcomes. Social Determinants of Health (SDOH) – conditions in which people are born, grow, live, work, and age – result in disparities in health care. The initiative seeks to develop screening methods that truly reflect the needs of patients and incorporate their voices throughout the process.
Involving Patients and Caregivers
The project will leverage the extensive network of the MOQC, working directly to formulate a protocol that screens for financial and health-related social needs. The ultimate aim is for patients to be connected with appropriate resources tailored to tackle their immediate concerns. This, in turn, is expected to enhance treatment adherence, leading to improved health outcomes and overall quality of life.
Voices in Healthcare
According to Alan Balch, CEO of the Patient Advocate Foundation, addressing social and financial needs must be an integral part of medical care rather than an afterthought. Balch emphasizes the necessity of understanding the broader context of patient experiences during their cancer journeys.
Building a Comprehensive Care Model
The collaborative efforts aim to create a comprehensive blueprint for caring for patients by asking them what they actually need. Rebekah Angove, PAF's executive vice president of research, explains that patients must play an active role in shaping care models that involve community services and clinics tailored to their unique requirements.
Focus on Underserved Populations
This initiative particularly targets small to medium-sized oncology practices that cater to low-income and under-resourced populations, often struggling to provide adequate screenings and interventions for social needs. By incorporating patients' insights at the forefront of every stage, from data collection to review, it ensures that the protocol developed is relevant and adaptable to various clinics and patient workflows.
Aiming for Broader Impact
Ultimately, this pioneering partnership seeks to identify best practices that can be replicated across various healthcare settings, thus advancing health equity efforts and meeting the diverse needs of all patients. The collaboration strives to create solutions founded on a composite understanding of the healthcare ecosystem, aimed at improving patient care and outcomes.
Collaboration Support
Support from Gilead Sciences, Inc. amplifies the objectives of this collaborative project, promoting patient-focused strategies within the healthcare framework.
About the Patient Advocate Foundation's Patient Insight Institute
Rooted in a 25-year legacy of advocacy, PAf's Patient Insight Institute is dedicated to fostering patient engagement in research to drive evidence-based healthcare changes. The Institute pursues critical investigation topics such as healthcare access, cost impact on treatment choices, and barriers low-income patients face. Their focus extends to ensuring that historically underrepresented voices are heard, allowing for greater inclusivity in shaping healthcare initiatives.
About the Michigan Oncology Quality Consortium
The Michigan Oncology Quality Consortium (MOQC) represents a collaborative quality initiative comprising over 55 practices throughout the state. With the capability to share data and best practices among oncology providers, MOQC works diligently to enhance cancer care and improve patient experiences across the board.
Frequently Asked Questions
What is the main goal of this partnership?
The main goal of the partnership is to develop a patient-centered screening protocol that addresses the social determinants of health affecting cancer patients.
Who is involved in this collaboration?
The collaboration involves the Patient Advocate Foundation's Patient Insight Institute, Michigan Oncology Quality Consortium, and Gilead Sciences, Inc.
What will the screening protocol focus on?
The protocol will focus on identifying financial and health-related social needs of patients to improve overall health outcomes.
How are patients being included in this initiative?
Patients are included through direct involvement in the data collection and the development of the screening protocol, ensuring their needs are prioritized.
Why is this project important for underserved populations?
The project aims to address healthcare gaps faced by underserved populations, improving access to vital resources and support.
